1. Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8+ T cells. Issue 2 (5th August 2020) Authors: Kumar, Sandeep; Singh, Sunil Kumar; Viswakarma, Navin; Sondarva, Gautam; Nair, Rakesh Sathish; Sethupathi, Periannan; Dorman, Matthew; Sinha, Subhash C; Hoskins, Kent; Thatcher, Gregory; Rana, Basabi; Rana, Ajay Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8+ T cells. Issue 2 (5th August 2020) Authors: Kumar, Sandeep; Singh, Sunil Kumar; Viswakarma, Navin; Sondarva, Gautam; Nair, Rakesh Sathish; Sethupathi, Periannan; Dorman, Matthew; Sinha, Subhash C; Hoskins, Kent; Thatcher, Gregory; Rana, Basabi; Rana, Ajay Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8+ T cells. Issue 2 (5th August 2020) Authors: Kumar, Sandeep; Singh, Sunil Kumar; Viswakarma, Navin; Sondarva, Gautam; Nair, Rakesh Sathish; Sethupathi, Periannan; Dorman, Matthew; Sinha, Subhash C; Hoskins, Kent; Thatcher, Gregory; Rana, Basabi; Rana, Ajay Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8+ T cells. Issue 2 (5th August 2020) Authors: Kumar, Sandeep; Singh, Sunil Kumar; Viswakarma, Navin; Sondarva, Gautam; Nair, Rakesh Sathish; Sethupathi, Periannan; Dorman, Matthew; Sinha, Subhash C; Hoskins, Kent; Thatcher, Gregory; Rana, Basabi; Rana, Ajay Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8+ T cells. Issue 2 (5th August 2020) Authors: Kumar, Sandeep; Singh, Sunil Kumar; Viswakarma, Navin; Sondarva, Gautam; Nair, Rakesh Sathish; Sethupathi, Periannan; Dorman, Matthew; Sinha, Subhash C; Hoskins, Kent; Thatcher, Gregory; Rana, Basabi; Rana, Ajay Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8+ T cells. Issue 2 (5th August 2020) Authors: Kumar, Sandeep; Singh, Sunil Kumar; Viswakarma, Navin; Sondarva, Gautam; Nair, Rakesh Sathish; Sethupathi, Periannan; Dorman, Matthew; Sinha, Subhash C; Hoskins, Kent; Thatcher, Gregory; Rana, Basabi; Rana, Ajay Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8+ T cells. Issue 2 (5th August 2020) Authors: Kumar, Sandeep; Singh, Sunil Kumar; Viswakarma, Navin; Sondarva, Gautam; Nair, Rakesh Sathish; Sethupathi, Periannan; Dorman, Matthew; Sinha, Subhash C; Hoskins, Kent; Thatcher, Gregory; Rana, Basabi; Rana, Ajay Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8+ T cells. Issue 2 (5th August 2020) Authors: Kumar, Sandeep; Singh, Sunil Kumar; Viswakarma, Navin; Sondarva, Gautam; Nair, Rakesh Sathish; Sethupathi, Periannan; Dorman, Matthew; Sinha, Subhash C; Hoskins, Kent; Thatcher, Gregory; Rana, Basabi; Rana, Ajay Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8+ T cells. Issue 2 (5th August 2020) Authors: Kumar, Sandeep; Singh, Sunil Kumar; Viswakarma, Navin; Sondarva, Gautam; Nair, Rakesh Sathish; Sethupathi, Periannan; Dorman, Matthew; Sinha, Subhash C; Hoskins, Kent; Thatcher, Gregory; Rana, Basabi; Rana, Ajay Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8+ T cells. Issue 2 (5th August 2020) Authors: Kumar, Sandeep; Singh, Sunil Kumar; Viswakarma, Navin; Sondarva, Gautam; Nair, Rakesh Sathish; Sethupathi, Periannan; Dorman, Matthew; Sinha, Subhash C; Hoskins, Kent; Thatcher, Gregory; Rana, Basabi; Rana, Ajay Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗